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The effects of two nitric oxide synthase (NOS) inhibitors with different isoform selectivity were
compared in a murine model of endotoxemia. Mice challenged with 70 mg/kg intraperitoneal (ip)
lipopolysaccharide (LPS) were treated 6 h after LPS with either NG-g-L-arginine methyl ester (L-
NAME, nonselective NOS inhibitor, 10–60 mg/kg), L-canavanine (selective inhibitor of inducible
NOS, 50–300 mg/kg), or saline (0.2 mL) given ip. In a subset of mice, plasma concentrations of
nitrate (NO breakdown product), lipase (pancreas injury), lactate dehydrogenase, and transaminases
(liver injury) were measured 16 h after LPS. Although both inhibitors reduced plasma nitrate, they
produced contrasting effects on survival and organ injury. L-NAME enhanced liver damage and
tended to accelerate the time of death, while L-canavanine significantly reduced mortality and had
no deleterious effects in terms of organ damage. These results indicate that nonselective NOS
inhibitors are detrimental in endotoxic shock and support the potential usefulness of selective
inducible NOS inhibitors in this setting.
Nitric oxide (NO) is a short-lived effector molecule that agents [1, 4, 5]. Thus, interest is now focusing on the identifica-
tion of compounds that would selectively reduce iNOS-depen-is produced from L-arginine by several NO synthase (NOS)
isoforms. Physiologically, small amounts of NO are produced dent NO production [1, 4].
Indeed, beneficial effects were recently reported in experi-by an endothelial constitutive NOS (ecNOS), which is involved
in the regulation of vascular tone and blood flow distribution mental models of septic shock that used various putatively
selective inhibitors of iNOS, such as aminoguanidine [6], L-[1]. On stimulation by bacterial products such as lipopolysac-
charide (LPS), and various cytokines, an inducible NOS (iNOS) canavanine [7], and S-substituted thiourea derivatives [4, 8].
However, these studies essentially focused on the hemody-is diffusely expressed, producing large amounts of NO for
prolonged periods, which have been shown to play a major namic and metabolic consequences of these inhibitors, with
only a limited interest towards their influence on mortality.role in the pathophysiology of septic and endotoxic shock [1].
The recognition of NO as an important mediator of septic The present study was therefore designed to address this issue,
by comparing the effects of the nonselective NOS inhibitorshock led to the proposal that the pharmacologic inhibition of
NO production could represent a useful adjunct in the treatment NG-g-L-arginine methyl ester (L-NAME) to those of L-canava-
nine, a selective iNOS inhibitor [7], on the mortality of endo-of this condition [1]. In support of this concept, it was recently
shown that mutant mice lacking the iNOS gene were conferred toxic shock in mice.
some protection against LPS-induced mortality [2], although
this finding has not been systematically reproduced [3]. Unfor-
Material and Methodstunately, such inhibition has been frequently reported to be
detrimental, and recent data suggest that this deleterious poten- Animals
tial might be a consequence of ecNOS blockade by nonselective
One hundred eighty-six Swiss-Webster female mice (6–8 weeks
old; mean weight, 25 g) were used in this study. Mice were housed
by groups of 10–15 animals with a light-night rhythm of 12 h–
12 h and had free access to food and water. An adaptation periodReceived 9 June 1997; revised 21 August 1997.
Presented in part: American Thoracic Society, New Orleans, May 1996; to these conditions of at least 2 weeks was observed before the
European Society of Intensive Care Medicine, Glasgow, Scotland, September animals were used for the experiments.
1996; Swiss Society of Intensive Care Medicine, Basel, September 1996.
All experiments were in agreement with the Swiss laws on animal experi-
mentation and were approved by the local ethical committee of the authors’
institution. Experimental Setup
Financial support: Institute of Pathophysiology, University Hospital, Lau-
sanne, Switzerland. Effects of NOS inhibitors on endotoxin lethality. One hundred
Reprints or correspondence: Dr. Lucas Liaudet, Critical Care Division, Dept. six mice were used in this experiment. At baseline, all animals were
of Internal Medicine (Service B), University Hospital, 1011 Lausanne, Switzer-
challenged with 70 mg/kg LPS intraperitoneally (ip), dissolved inland.
0.2 mL of normal saline. Six hours later, mice were assigned to
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one of the following ip treatments: L-NAME, 10 mg/kg (n  16);q 1998 by The University of Chicago. All rights reserved.
0022–1899/98/7701–0019$02.00 L-NAME, 60 mg/kg (n  16); L-canavanine, 50 mg/kg (n  25);
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L-canavanine, 300 mg/kg (n  25); normal saline, 0.2 mL (control evidenced by ruffled fur, anorexia, lethargy, and tachypnea.
group, n  24). NOS inhibitors were administered 6 h after ip Later in the course of endotoxic shock, mice became progres-
LPS to account for the lag period of several hours necessary for sively cyanotic and deeply comatose. Death was preceded by
iNOS to be expressed on an induction stimulus [1]. Indeed, diffuse muscular spasms and convulsions.
expression of iNOS [9] and elevation of plasma nitrogen oxides Figure 1 illustrates the survival curves of the different treat-
[10] have been reported in mice 6 h after ip LPS administration.
ment groups of mice. All mice treated with saline or L-NAME
Mortality was noted at 8-h intervals until 48 h after LPS and
(at either 10 or 60 mg/kg) died from LPS administration, deaththen at 24-h intervals until day 7.
tending to occur earlier in mice receiving L-NAME (at bothThe different doses of NOS inhibitors were adapted from the
doses), but this difference was not statistically significant. L-results of previous experiments, in which we found that total doses
canavanine afforded a significant protection against LPS-in-of 25 mg/kg L-NAME and 100 mg/kg L-canavanine were able to
efficiently blunt NO production in endotoxemic rats [7]. The dose duced mortality, at either 50 mg/kg (13/25 surviving mice at
of LPS used in the present study was chosen on the basis of pilot day 7) or 300 mg/kg (7/25 surviving mice), without significant
experiments, in which we found that this dose was responsible for difference between doses.
a 100% lethality at 48 h. NO production and indicators of organ damage. It was
Effects of NOS inhibitors on indicators of NO production and not possible to obtain plasma from mice treated with 60 mg/
organ damage in endotoxic shock. Eighty mice were used in this kg L-NAME, since all mice in this group had died at the time
experiment. The animals were initially challenged with 70 mg/kg
of blood sampling (16 h after LPS administration). Figure 2
LPS ip. Six hours later, they received one of the following ip
shows plasma nitrate results in the remaining 4 groups of mice.treatments: L-NAME, 10 mg/kg (n  16); L-NAME, 60 mg/kg (n
In the control group, nitrate reached 2356 { 91 mmol/L. Treat- 16); L-canavanine, 50 mg/kg (n  16); L-canavanine, 300 mg/
ment with L-canavanine at either doses and L-NAME (10 mg/kg (n  16); normal saline, 0.2 mL (control group, n  16).
kg) reduced the level of plasma nitrate, this effect being mostThen, 10 h later (16 h after LPS), mice were anesthetized with ip
pentobarbital (200 mg/kg), the thorax was opened, and the heart pronounced in the L-NAME group (1059 { 105 mmol/L; P 
was punctured with a 22-gauge needle, allowing0.5 mL of blood .05 vs. saline control), followed by the high dose (300 mg/kg)
to be sampled. The sampled blood was centrifuged at 2000 g for of L-canavanine (1536 { 260 mmol/L; P  .05 vs. saline; P
15 min. Plasma was then assayed for concentrations of alanine not significant vs. L-NAME) and the low dose (50 mg/kg) of
aminotransferase (ALT), aspartate aminotransferase (AST), lactate
L-canavanine (1890 { 105 mmol/L; P  .051 vs. saline; P not
dehydrogenase (LDH), and pancreatic lipase, measured spectro- significant vs. L-canavanine 300 mg/kg; P .05 vs. L-NAME).
photometrically with a selective analyzer (Hitachi Scientific Instru-
Figure 3 illustrates the concentrations of plasma AST, ALT,
ments, Mountain View, CA). Plasma was also assayed for concen-
LDH, and lipase obtained in the 4 treatment groups. Whiletrations of nitrate, which were determined by a spectrophotometric
L-canavanine had no significant influence on these differentmethod based on NADPH oxidation and adapted on an automated
variables, L-NAME produced a significant increase in plasmaanalyzer (Cobas; Roche, Basel, Switzerland), as previously de-
AST, ALT, and LDH, and it tended to increase plasma lipase.scribed [11].
DiscussionMaterials
The pharmacologic inhibition of NO production has beenLPS (Escherichia coli O127:B8), L-NAME hydrochloride, and
L-canavanine freebase were all purchased from Sigma (Buchs, recently proposed as a potentially interesting adjunct to septic
Switzerland) and were freshly dissolved in isotonic saline before shock therapy [1, 12]. However, it is increasingly recognized
use. that nonselective NOS inhibitors are more detrimental than
beneficial in this setting and that the selective targeting of the
inducible isoform of NOS would be preferable [1]. In a previ-Statistical Methods
ous study [7], we reported that the survival of endotoxemic
Survival curves were compared using the log rank test, and P mice was markedly improved when animals were pretreated .05 was considered significant. Comparisons between values with L-canavanine, a selective inhibitor of iNOS, contrasting
for nitrate, AST, ALT, LDH, and lipase in the different groups
with no beneficial influence of pretreatment with L-NAME, a
were made with analysis of variance. When the F value was sig-
nonselective NOS inhibitor. The present study largely extendsnificant at the 5% level, further pairwise comparisons were made
these results by showing that L-canavanine is also protectivewith saline treatment as a control. Statistical significance was as-
when given 6 h after LPS administration, at a time when micesigned to P  .05. Results of plasma nitrate, AST, ALT, LDH,
already show severe signs of systemic toxicity.and lipase are expressed as means { SEs.
Administration of the nonselective NOS inhibitor L-NAME
was not protective and in fact tended to accelerate death (figure
Results
1). In addition, L-NAME favored the development of organ
injury in endotoxemic mice, as shown by a significant increaseSurvival experiment. Administration of LPS was followed
by the rapid development (within 1 h) of signs of toxicity, as in plasma transaminases and LDH, as well as by an important
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Figure 1. Survival curves obtained in mice chal-
lenged with 70 mg/kg lipopolysaccharide (LPS) intra-
peritoneally at baseline and treated intraperitoneally
6 h later with either normal saline, 0.2 mL (n  24),
L-canavanine, 300 mg/kg (n  25), L-canavanine, 50
mg/kg (n  25), NG-g-L-arginine methyl ester (L-
NAME), 60 mg/kg (n  16), or L-NAME, 10 mg/kg
(n  15). * P  .05 vs. saline treatment (log rank
test).
trend toward an increase in plasma lipase (figure 3). These culation, platelet aggregation and endothelium-leukocytes in-
teractions, thereby favoring tissue hypoperfusion [19, 20], mi-results fully agree with many previous studies showing that
nonselective NOS inhibitors either do not influence survival crothrombi formation [21], and leukocyte infiltration [15, 16].
Taken together, these data do not support the use of nonselec-[13] or enhance mortality [14–16] in septic or endotoxemic
animals. The only exception is the study by Teale and Atkinson tive NOS inhibitors in septic shock therapy.
In striking contrast with the effects of L-NAME, we found[17], who found that the nonselective NOS inhibitor mono-
methyl-L-arginine (L-NMMA) conferred some survival advan- that L-canavanine, both at 50 and 300 mg/kg, afforded a sig-
nificant protection against LPS-mediated mortality (figure 1)tage when administered concomitantly with imipenem in a mu-
rine model of peritonitis. Our finding of increased signs of and did not reproduce the detrimental effects of L-NAME on
organ damage (figure 3). However, it is noteworthy that theorgan injury also confirms previous results obtained with non-
selective NOS inhibitors in experimental septic shock [16, 18]. high dose of L-canavanine appeared somewhat less protective,
since it produced a survival rate of 28% compared with 52%It has been proposed that these deleterious effects might reflect
the loss of the regulatory functions of ecNOS on the microcir- at the low dose. Although not statistically significant, this trend
Figure 2. Plasma nitrate concentrations measured
in mice challenged with 70 mg/kg lipopolysaccharide
(LPS) intraperitoneally at baseline and treated intra-
peritoneally 6 h later with either normal saline, 0.2
mL (n  16), L-canavanine, 300 mg/kg (n  16), L-
canavanine, 50 mg/kg (n  16), or NG-g-L-arginine
methyl ester (L-NAME), 10 mg/kg (n  15). Blood
samples were obtained 16 h after LPS. Data are means
{ SEs. * P  .05 vs. saline treatment.
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Figure 3. Plasma concentrations
of aspartate aminotransferase (AST),
alanine aminotransferase (ALT),
lactate dehydrogenase (LDH), and
pancreatic lipase, measured in mice
challenged with 70 mg/kg lipopoly-
saccharide (LPS) intraperitoneally at
baseline and treated intraperitoneally
6 h later with either normal saline,
0.2 mL (n  16), L-canavanine, 300
mg/kg (n  16), L-canavanine, 50
mg/kg (n  16), NG-g-L-arginine
methyl ester (L-NAME), 10 mg/kg
(n  15). Blood samples were ob-
tained 16 h after LPS. Data are
means { SEs. * P  .05 vs. saline
treatment.
might indicate nonspecific toxicity of L-canavanine at high ule of blood sampling 16 h after LPS was too early, that is, at
a time when organ injury was still insufficiently developed todoses. However, this is an unlikely possibility, since the main
toxicity of L-canavanine reported in rodents is pancreatic dam- detect the influence of L-canavanine. Finally, it is worth noting
that plasma transaminases, LDH and lipase, while sensitiveage [22], a potential side effect that is not supported by our
data of plasma lipase (figure 3). A distinct possibility might indicators of tissue damage, do not provide information regard-
ing cell function. Therefore, the lack of effect of L-canavaninebe the loss of iNOS selectivity at high doses. Indeed, very high
concentrations of L-canavanine (2 mM) were able to inhibit on these biologic markers does not rule out some beneficial
influence of this compound on LPS-induced organ dysfunction,the activity of ecNOS in vitro [23].
Although the mechanisms by which L-canavanine protected although this issue remains speculative.
NO production was assessed by measuring the plasma levelsmice from LPS-induced mortality cannot be inferred directly
from our data, several hypotheses may be advanced. First, of nitrate, the stable oxidation product of NO in blood. In
endotoxemic mice treated with saline, nitrate levels weredecreasing NO production may have reduced oxidative stress
by slowing the formation of peroxynitrite, a highly reactive 2000 mmol/L, indicating a massive synthesis of NO in these
animals, given a normal basal concentration of plasma nitrogenspecies formed from the reaction of NO with the superoxide
radical [1]. Second, the selective inhibition of iNOS may have oxides (nitrate and nitrite) of 60 mmol/L in mice [10]. All
treatments reduced plasma nitrate (figure 2), although to differ-improved tissue oxygenation and energy metabolism, either by
limiting the LPS-induced fall in cardiac output, as previously ent degrees, the reduction being marginally significant with the
low dose of L-canavanine (020%; P .051), intermediate withreported in endotoxemic rats [7, 24], by improving microcircu-
latory blood flow distribution through the removal of excess the high dose of L-canavanine (035%; P  .05), and most
pronounced with L-NAME (055%; P  .05).vasodilator NO [1], or finally, by preventing an NO-mediated
block of high-energy phosphate generation at the cellular level These results imply that iNOS was not similarly inhibited
by the different regimens. Therefore, one could argue that the[25]. Indeed, we provided evidence that L-canavanine enhances
ATP concentrations in various organs during rat endotoxic contrasted effects of our treatments on survival might reflect
different levels of iNOS blockade rather than selective versusshock [11].
In spite of the evident protection afforded by L-canavanine, nonselective NOS inhibition. Although we can not formally
rule out this hypothesis, it seems unlikely, for the followingit was somewhat puzzling that it did not affect the biologic
markers of tissue injury (figure 3). This may suggest that iNOS- reasons: while the reduction in plasma nitrate achieved with
L-canavanine at a high dose (300 mg/kg) and L-NAME wasmediated NO production was not a critical factor in the occur-
rence of organ damage in our conditions, at least considering not statistically different, only L-canavanine was protective;
also, in studies by other investigators in endotoxemic [15] orthe liver and the pancreas. Another possibility is that the sched-
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septic mice [13], in which treatment with the nonselective NOS shock, with a potential impact on outcome. Further studies
should therefore be done to assess the influence of selectiveinhibitors L-NAME or L-NMMA achieved reductions in plasma
nitrogen oxides comparable to or even smaller than those of iNOS inhibition in hyperdynamic models of septic shock. Sec-
ond, our results were obtained in an endotoxic and not bacter-L-canavanine in our study, survival was either not improved
[13] or depressed [15]. Taken together, these data support that emic model of septic shock. This distinction is of paramount
importance, in view of the properties of NO as a microbicidalselective rather than partial inhibition of iNOS was the critical
factor underlying the contrasted effects of L-canavanine and L- agent [2]. Therefore, future studies should be designed to assess
the effects of selective iNOS inhibition in experimental modelsNAME in our endotoxemic mice.
The effects of L-canavanine noted in the present study extend of septic rather than endotoxic shock.
In conclusion, the data presented herein confirm that nonse-the results of previous works showing beneficial effects of
other selective iNOS inhibitors, chemically unrelated to L-cana- lective NOS inhibition does not give any survival advantage
to endotoxemic mice and rather appears detrimental in thisvanine, in experimental septic shock. Aminoguanidine and one
analogue, 1-amino-2-hydroxy-guanidine, reduced organ injury setting. By contrast, the significant protection afforded by L-
canavanine is in agreement with convergent information ob-and metabolic acidosis in endotoxemic rats [5, 26]. Aminogua-
nidine was also shown to reduce bacterial translocation from tained with other selective iNOS inhibitors in similar experi-
mental conditions. This supports the potential usefulness ofthe gut of endotoxemic rats [27] and to improve survival of
endotoxemic mice [6]. Thiourea derivatives, such as S-methyl- this class of agents in the adjunctive therapy of septic shock.
isothiourea and aminoethylisothiourea, also produced benefi-
cial hemodynamic and metabolic effects in endotoxic shock
rats [4, 8], and S-methyl-isothiourea was shown to improve Acknowledgments
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